Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

被引：0
|
作者：
Fardin Dolatimehr
Hamidreza Karimi-Sari
Mohammad Saeid Rezaee-Zavareh
Seyed Moayed Alavian
Bita Behnava
Mohammad Gholami-Fesharaki
Heidar Sharafi
机构：
[1] Student Research Committee,Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL)
[2] Baqiyatallah University of Medical Sciences,Department of Biostatistics, Faculty of Medical Sciences
[3] Meta-analysis Study Group,undefined
[4] Iran Hepatitis Network,undefined
[5] Baqiyatallah University of Medical Sciences,undefined
[6] Middle East Liver Disease (MELD) Center,undefined
[7] Tarbiat Modares University,undefined
来源：
DARU Journal of Pharmaceutical Sciences | / 25卷
关键词：
Hepatitis C; Sofosbuvir; Ribavirin; Pegylated-interferon; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FDA Perspective on Sofosbuvir Therapy for Patients With Chronic Hepatitis C Virus Genotype 1 Infection Who Did Not Respond to Treatment With Pegylated Interferon and Ribavirin
    Mishra, Poonam
    Florian, Jeffry
    Qi, Karen
    Zeng, Wen
    Naeger, Lisa K.
    Donaldson, Eric
    Connelly, Sarah
    O'Rear, Jules
    Price, Dionne
    Murray, Jeffrey
    Birnkrant, Debra
    GASTROENTEROLOGY, 2014, 147 (06) : 1196 - 1200
  • [22] Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis
    Thong, Vo Duy
    Poovorawan, Kittiyod
    Tangkijvanich, Pisit
    Wasitthankasem, Rujipat
    Vongpunsawad, Sompong
    Poovorawan, Yong
    INTERVIROLOGY, 2015, 58 (06) : 373 - 381
  • [23] Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection
    Pawlotsky, Jean-Michel
    Flisiak, Robert
    Sarin, Shiv K.
    Rasenack, Jens
    Piratvisuth, Teerha
    Chuang, Wan-Long
    Peng, Cheng-Yuan
    Foster, Graham R.
    Shah, Samir
    Wedemeyer, Heiner
    Hezode, Christophe
    Zhang, Wei
    Wong, Kelly A.
    Li, Bin
    Avila, Claudio
    Naoumov, Nikolai V.
    HEPATOLOGY, 2015, 62 (04) : 1013 - 1023
  • [24] Pegylated and non-pegylated interferon-alfa and ribavirin for the treatment of mild chronic hepatitis C: A systematic review and meta-analysis
    Hartwell, Debbie
    Shepherd, Jonathan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (01) : 56 - 62
  • [25] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [26] Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review
    Mucenic, Marcos
    de Melo Brandao, Ajacio Bandeira
    Marroni, Claudio Augusto
    Fleck Junior, Alfeu de Medeiros
    Zanotelli, Maria Lucia
    Leipnitz, Ian
    Meine, Mario Henrique
    Kiss, Guillermo
    Martini, Juliano
    Schlindwein, Eduardo Soares
    Costabeber, Ane Micheli
    Rodrigues Sacco, Fernanda Karlinsky
    Rossato, Giovana
    Cracco Cantisani, Guido Pio
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2019, 61
  • [27] Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis
    Tao, Tingting
    Jiang, Xuehua
    Chen, Yuehong
    Song, Yiran
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 55 : 56 - 71
  • [28] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [29] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [30] Ledipasvir/sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotype 1: A pairwise meta-analysis
    Ferreira, Vinicius L.
    Assis Jarek, Nayara A.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Wiens, Astrid
    Muzzillo, Dominique A.
    Pontarolo, Roberto
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 749 - 755
12345